Xie S - Search Results

1

Gene signature of m⁶A RNA regulators in diagnosis, prognosis, treatment, and immune microenvironment for cervical cancer.

Wang S, Ding B, Wang S, Yan W, Xia Q, Meng D, Xie S, Shen S, Yu B, Liu H, Hu J, Zhang X. Wang S, et al. Among authors: xie s. Sci Rep. 2022 Oct 21;12(1):17667. doi: 10.1038/s41598-022-22211-2. Sci Rep. 2022. PMID: 36271283 Free PMC article.

2

Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer.

Meng D, Jin H, Zhang X, Yan W, Xia Q, Shen S, Xie S, Cui M, Ding B, Gu Y, Wang S. Meng D, et al. Among authors: xie s. Cancer Cell Int. 2021 Jul 8;21(1):362. doi: 10.1186/s12935-021-02073-w. Cancer Cell Int. 2021. PMID: 34238288 Free PMC article.

3

Esophageal Cancer Associated Immune Genes as Biomarkers for Predicting Outcome in Upper Gastrointestinal Tumors.

Zhu C, Xia Q, Gu B, Cui M, Zhang X, Yan W, Meng D, Shen S, Xie S, Li X, Jin H, Wang S. Zhu C, et al. Among authors: xie s. Front Genet. 2021 Jul 19;12:707299. doi: 10.3389/fgene.2021.707299. eCollection 2021. Front Genet. 2021. PMID: 34349789 Free PMC article.

4

Fanconi Anemia Pathway Genes Advance Cervical Cancer via Immune Regulation and Cell Adhesion.

Wang S, Ding B, Cui M, Yan W, Xia Q, Meng D, Shen S, Xie S, Jin H, Zhang X. Wang S, et al. Among authors: xie s. Front Cell Dev Biol. 2021 Nov 15;9:734794. doi: 10.3389/fcell.2021.734794. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34869316 Free PMC article.

5

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers.

Cui M, Xia Q, Zhang X, Yan W, Meng D, Xie S, Shen S, Jin H, Wang S. Cui M, et al. Among authors: xie s. Front Genet. 2022 Jan 11;12:688207. doi: 10.3389/fgene.2021.688207. eCollection 2021. Front Genet. 2022. PMID: 35087563 Free PMC article.

6

Construction of a hypoxia-immune-related prognostic model and targeted therapeutic strategies for cervical cancer.

Xie S, Ding B, Wang S, Zhang X, Yan W, Xia Q, Meng D, Shen S, Yu B, Liu H, Hu J, Wang S. Xie S, et al. Int Immunol. 2022 Jul 4;34(7):379-394. doi: 10.1093/intimm/dxac017. Int Immunol. 2022. PMID: 35561666

7

Comprehensive analysis of prognosis-related alternative splicing events in ovarian cancer.

Wang S, Wang S, Zhang X, Meng D, Xia Q, Xie S, Shen S, Yu B, Hu J, Liu H, Yan W. Wang S, et al. Among authors: xie s. RNA Biol. 2022 Jan;19(1):1007-1018. doi: 10.1080/15476286.2022.2113148. RNA Biol. 2022. PMID: 35980273 Free PMC article.

8

Post-transcriptional regulation of tumor suppressor gene lncRNA CARMN via m⁶A modification and miRNA regulation in cervical cancer.

Yu B, Li X, Yan W, Ding B, Zhang X, Shen S, Xie S, Hu J, Liu H, Chen X, Nie Y, Liu F, Zhang Y, Wang S. Yu B, et al. Among authors: xie s. J Cancer Res Clin Oncol. 2023 Sep;149(12):10307-10318. doi: 10.1007/s00432-023-04893-x. Epub 2023 Jun 5. J Cancer Res Clin Oncol. 2023. PMID: 37273106

9

An improved UAV target detection algorithm based on ASFF-YOLOv5s.

Shen S, Zhang X, Yan W, Xie S, Yu B, Wang S. Shen S, et al. Among authors: xie s. Math Biosci Eng. 2023 Apr 18;20(6):10773-10789. doi: 10.3934/mbe.2023478. Math Biosci Eng. 2023. PMID: 37322960 Free article.

10

LINC00426, a novel m⁶A-regulated long non-coding RNA, induces EMT in cervical cancer by binding to ZEB1.

Shen S, Jin H, Zhang X, Zhang Y, Li X, Yan W, Xie S, Yu B, Hu J, Liu H, Chen X, Nie Y, Liu F, Tang M, Gu Y, Wang S. Shen S, et al. Among authors: xie s. Cell Signal. 2023 Sep;109:110788. doi: 10.1016/j.cellsig.2023.110788. Epub 2023 Jun 29. Cell Signal. 2023. PMID: 37392859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,417 results

Search Page

Filters